Stalemate in Congress puts spending plans on hold.
Laura Niedernhofer is counting her pennies. The mid-career molecular biologist moved last year to the Scripps Research Institute’s campus in Jupiter, Florida — a risky decision that saw her building a new laboratory group at a time when the US government was cutting its support for science. In June, Niedernhofer abandoned one of her main lines of research — reducing the toxicity of cancer drugs — after the National Institutes of Health (NIH) rejected her grant application. In July, the agency approved a second grant, allowing her to keep another research thrust alive — on the molecular mechanisms of ageing. But the NIH cut the award by 18%, preventing her from hiring an additional postdoctoral researcher. (...) Nature, by Lauren Morello, 11 Septembre 2013